Back to Search
Start Over
Secretin infusion decreases food intake in healthy men - a randomized, placebo-controlled, double-blind, crossover study.
- Source :
-
European journal of endocrinology [Eur J Endocrinol] 2024 Nov 18. Date of Electronic Publication: 2024 Nov 18. - Publication Year :
- 2024
- Publisher :
- Ahead of Print
-
Abstract
- Design: The hormone secretin, best known for regulating pH in the duodenum, has anorectic properties in mice proposedly mediated via secretin-induced brown adipose tissue (BAT) activation. We investigated the effects of exogenous secretin on ad libitum food intake, BAT activity, and postprandial physiology in healthy male volunteers.<br />Methods: In a randomized, placebo-controlled, double-blind, crossover study, 25 healthy men underwent two 5-hour i.v. infusions of secretin (1 pmol/kg/min) and placebo (saline), respectively, with an interposed two-month wash-out period. After 30 min of infusion, a standardized liquid mixed meal was ingested and after 5 hours, food intake and meal duration were assessed during an ad libitum meal test. BAT activity was assessed regularly by thermal imaging-measured supraclavicular skin temperature.<br />Results: Compared to placebo, secretin significantly decreased ad libitum food intake by 173 ± 88 kcal [95% CI 0.76 to 0.99, P = 0.039], but did not alter ad libitum meal duration. Secretin acutely decreased BAT activity but increased it postprandially compared to placebo. Acetaminophen-assessed gastric emptying was not affected by exogenous secretin, but secretin increased gallbladder volume, bile acid synthesis, and circulating levels of lipase, amylase and triglycerides, while decreasing plasma Na+. Compared to placebo, secretin infusion was associated with 24.0 ± 10.8% (95% CI 0.3 to 1, P = 0.025) more adverse events (headache, nausea, diarrhoea, and vomiting).<br />Conclusions: In healthy men, secretin infusion decreased ad libitum food intake concomitantly with a postprandial increase in BAT activity as assessed by thermal imaging-measured supraclavicular skin temperature.<br />Trial Registration: Clinicaltrials.gov, NCT04613700.<br /> (© The Author(s) 2024. Published by Oxford University Press on behalf of European Society of Endocrinology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.)
Details
- Language :
- English
- ISSN :
- 1479-683X
- Database :
- MEDLINE
- Journal :
- European journal of endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- 39556772
- Full Text :
- https://doi.org/10.1093/ejendo/lvae147